EUVIMEDEUVIMED entdecken
Crossref

Thirty-Day Outcomes of Breast Reduction Surgery in Patients with Diabetes Mellitus

Renxi Li, Yuchen Lu, Hari Ramesh, William Huang, Yueyao Zhu, Bharat Ranganath

Breast Global Journal · 2024

DOI: 10.4103/bgj.bgj_1_25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Global Journal, 2024. Verfasst von Renxi Li und 5 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A bstract Background: Diabetes mellitus (DM) has been recognised as a significant risk factor for impaired wound healing and increased complications after surgery. However, the specific impact of DM on breast reduction surgery outcomes remains unclear. This study aimed to evaluate the 30-day postoperative outcomes of breast reduction surgery in patients with DM using a large-scale, multi-institutional database. Materials and Methods: Adult female patients who underwent breast reduction surgery were selected from the American College of Surgeons National Surgical Quality Improvement Program database from 2005 to 2022. Cases related to breast cancer, breast reconstruction, and lymph node mapping/biopsy/dissections were excluded. A 1:2 propensity-score matching was used to balance demographics and preoperative characteristics between DM and non-DM patients. Thirty-day postoperative outcomes were examined.

Results

There were 2937 (4.97%) DM and 56,138 non-DM patients who underwent breast reduction surgery. DM patients were more likely to be non-White and have more advanced age and higher comorbidity burdens. After 1:2 propensity-score matching, all DM patients were matched to 5763 non-DM patients. DM patients had higher risks of wound complications (6.38% vs. 5.17%, P = 0.02), bleeding requiring transfusion (0.72% vs. 0.35%, P = 0.02), and 30-day readmission (2.93% vs. 2.06%, P = 0.01). Hospital length of stay was also longer in DM patients (0.56 ± 2.56 vs. 0.38 ± 1.76 days, P < 0.01).

Conclusion

DM was found to be an independent risk factor for 30-day complications after breast reduction surgery. These findings can help with preoperative risk stratification for DM patients. Postoperative complications in these patients should be closely monitored and proactively managed to optimise outcomes.

Zitieren

APA

Li, R., Lu, Y., Ramesh, H., Huang, W., Zhu, Y., & Ranganath, B. (2024). Thirty-Day Outcomes of Breast Reduction Surgery in Patients with Diabetes Mellitus. Breast Global Journal. https://doi.org/10.4103/bgj.bgj_1_25

Vancouver

Li R, Lu Y, Ramesh H, Huang W, Zhu Y, Ranganath B. Thirty-Day Outcomes of Breast Reduction Surgery in Patients with Diabetes Mellitus. Breast Global Journal. 2024. doi:10.4103/bgj.bgj_1_25

BibTeX
@article{Li2024,
  author = {Li, Renxi and Lu, Yuchen and Ramesh, Hari and Huang, William and Zhu, Yueyao and Ranganath, Bharat},
  title = {Thirty-Day Outcomes of Breast Reduction Surgery in Patients with Diabetes Mellitus},
  journal = {Breast Global Journal},
  year = {2024},
  doi = {10.4103/bgj.bgj_1_25}
}
Kostenlos starten →